Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Sleep Disorders in CKD and ESRD
NCT01922999Phase 3Unknown
- Sponsor
- Southeast Renal Research Institute
- Start
- Dec 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin in sleep disorder, sponsored by Southeast Renal Research Institute. Status: unknown.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on NCT01922999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922999.